Ounce of Prevention is a weekly column which presents recommendations for preventative services derived from The United ...

Progression-free survival improvement and drug costs make zanubrutinib a more cost-effective option in relapsed or refractory ...

In a statistical analysis, Brukinsa resulted in fewer cases of disease progression or death and resulted in lower overall healthcare costs than Imbruvica in patients with chronic lymphocytic leukemia.

PUTRAJAYA: Drug addicts are turning to the dark web to get their hands on substances, which will be delivered right to their doorsteps, according to the National Anti-Drugs Agency (AADK).

BALTIMORE — Thousands of miles from a manufacturing plant in China, where the key active ingredient in heparin is sourced, Wanda Crowell receives a daily infusion of the drug in her bed at Johns ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday.

For more information about these drugs, including details about their uses, see these in-depth articles on Rybelsus and Ozempic. See the list below to learn whether Rybelsus or Ozempic is ...

MORE: Popular weight loss drugs in tight supply as Zepbound shortage could last through June Padula added that these companies use their profits in different ways including investing in research ...

Speaking to The Post, the veteran heart doctor tackled a drug that is commonly prescribed ... 1.3 years with elevated norepinephrine levels in their blood.” Here comes the however.

MANILA, Philippines — Former President Rodrigo Duterte’s lead counsel appeared to have “no knowledge” of who the victims of his war on drugs are ... as proof of their identity to either ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors, representing an innovative approach to metabolic health. Prices range from Rs3,500 to Rs4,375 per vial.